Around the Table: Automation in Quick-Service Restaurants

 

In the age of technology, convenience reigns king. In the quick-service restaurant (QSR) industry, where convenience and speed are part of the product, technology is a natural business partner. “Around the Table,” explores how automation has made its way into franchises all over the country, with the full extent of its capabilities still untapped. Antunes guests Steve Gauger, Senior Vice President of Advanced Development & Automation, and Dan Hartlein, President, speak decisively about automation’s potential to improve quick-service system, customer satisfaction, and profits.

The term “automation,” often brings to mind visions of intricate machines roving around autonomously. But Hartlein and Gauger assure that automation doesn’t have to be that complicated, or wildly futuristic. In fact, Antunes designs automated programs that integrate into a QSR’s already established kitchen space, resulting in little disruption to established processes.

Whatsmore, automating need not be a giant change. In fact, small, granular changes can have major ripple effects in efficiency and profits. From cutting slices of cheese, to fishing out pickle spears, automating these small tasks in the assembly line can produce drastic changes in QSR performance.

As the COVID-19 sits heavy in everyone’s thoughts, Hartlein and Gauger point out the hygienic benefits of automated processes, emphasizing the consumer’s growing habits of ordering-in or delivery. But will automation steal jobs from people? Gauger and Hartlein assure that’s not the case.

With automation still breaking ground in the quick-service industry, the possibilities are endless and processes are ripe for improvement.

For the latest news, videos, and podcasts in the Food & Beverage Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More
vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More